EUVIMEDEUVIMED entdecken
Vergleichsstudie

A cost-effectiveness estimation of the Attempted Suicide Short Intervention Programme (ASSIP)

Max Lelie iD, Riet Parmentier iD, Eva de Jaegere iD, Steven Simoens iD, Lieven Annemans iD, Koen Putman iD

Expert Review of Pharmacoeconomics & Outcomes Research · 2025

DOI: 10.1080/14737167.2025.2497877 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Expert Review of Pharmacoeconomics & Outcomes Research, 2025. Verfasst von Max Lelie und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, Vrije Universiteit Brussel, Brussels, Belgium. Hauptthemen laut MEDLINE: Suicide, Attempted, Health Care Costs, Mental Health Services. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Health Technology Assessment study of ASSIP.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Patients who have previously attempted suicide are at a substantially increased risk of a repeated attempt. We have conducted a cost-utility analysis of the Attempted Suicide Short Intervention Programme (ASSIP) and compared it with treatment as usual in a Flemish population. METHODS: A closed-cohort Markov-model was used to simulate suicide over a time-horizon of 20 years in a cohort of prior suicide attempt patients. This model is used to estimate Incremental Cost Effectiveness Ratios (ICERs) from societal and healthcare perspectives. A separate 'tipping-point' scenario was included, where the treatment effectiveness regresses over time. RESULTS: ASSIP is shown to be a dominant strategy from the societal perspective and cost-effective from a healthcare perspective: the ICER after 10 years is € 1,133 and after 20 years € 304. In the tipping-point scenario, an regression of up to 82,7% after the intervention remains cost-effective, assuming an ICER threshold of € 44000 per QALY. CONCLUSION: Our study found that ASSIP is cost-effective in the Flemish region, saving both healthcare costs and societal expenses over time. Implementing ASSIP could provide significant economic and health benefits within 10 years, making it a valuable investment for improving mental health care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Suicide, AttemptedHealth Care CostsMental Health ServicesHumansCost-Benefit AnalysisQuality-Adjusted Life YearsMarkov ChainsBelgiumTime FactorsCohort StudiesModels, EconomicFemaleMaleAdult

Stichwörter der Autor:innen

ASSIPAttempted Suicide Short Intervention Programmecost-utility analysishealth economic estimationsuicide preventionsuicide re-attempts

Autor:innen und Institutionen

  • Department of Public Health, Vrije Universiteit Brussel, Brussels, Belgium.
  • Eenheid voor Zelfmoordonderzoek, Ghent University, Ghent, Belgium.
  • Faculty of Pharmaceutical Sciences, Katholieke Universiteit, Leuven, Belgium.
  • Department of Public Health and Primary Care, Ghent University, Ghent, Belgium.

ORCID-Profile: Max Lelie, Riet Parmentier, Eva de Jaegere, Steven Simoens, Lieven Annemans, Koen Putman

Förderung

  • Health Technology Assessment study of ASSIP

Zitieren

APA

Lelie, M., Parmentier, R., de Jaegere, E., Simoens, S., Annemans, L., & Putman, K. (2025). A cost-effectiveness estimation of the Attempted Suicide Short Intervention Programme (ASSIP). Expert Review of Pharmacoeconomics & Outcomes Research. https://doi.org/10.1080/14737167.2025.2497877

Vancouver

Lelie M, Parmentier R, de Jaegere E, Simoens S, Annemans L, Putman K. A cost-effectiveness estimation of the Attempted Suicide Short Intervention Programme (ASSIP). Expert Review of Pharmacoeconomics & Outcomes Research. 2025. doi:10.1080/14737167.2025.2497877

BibTeX
@article{Lelie2025,
  author = {Lelie, Max and Parmentier, Riet and de Jaegere, Eva and Simoens, Steven and Annemans, Lieven and Putman, Koen},
  title = {A cost-effectiveness estimation of the Attempted Suicide Short Intervention Programme (ASSIP)},
  journal = {Expert Review of Pharmacoeconomics & Outcomes Research},
  year = {2025},
  doi = {10.1080/14737167.2025.2497877}
}
Kostenlos starten →